Saluda Medical is a commercial‑stage medical device company focused on developing treatments for chronic neurological conditions using its novel closed‑loop neuromodulation platform. The company’s proprietary technology senses and measures neural responses to stimulation and automatically adjusts therapy based on real‑time neurophysiological feedback.
Saluda Medical’s first product, the Evoke® System, is designed to deliver known, consistent, and personalized spinal cord stimulation therapy by objectively measuring neural responses and maintaining therapy within a prescribed therapeutic window. Saluda Medical is headquartered in Minneapolis, Minnesota.
At Saluda, we challenge boundaries. We innovate and think beyond the conventional. Our focus is to revolutionize the standard of care in neuromodulation to positively impact patient’s lives.
The Director / Sr. Director of Upstream Marketing will own Saluda's global product portfolio strategy and the pipeline of new products, serving as the voice of the market inside the company. This leader will define where Saluda plays next — identifying unmet clinical needs, shaping product requirements, building business cases, and guiding new products from concept through development to launch readiness.
Reporting to the VP of Marketing, this role partners closely with R&D, Clinical, Regulatory, and Finance to prioritize the pipeline, and with Downstream Marketing and Sales to ensure a seamless handoff from development to commercialization. It is a high-visibility role that directly shapes Saluda's multi-year growth trajectory.
What You’ll Do:
Portfolio Strategy & Roadmap
- Own the multi-year global product portfolio strategy and roadmap across the Evoke platform and adjacent opportunities, aligned to corporate growth objectives
- Continuously assess portfolio performance, lifecycle position, and white-space opportunities; recommend investment, sustain, and sunset decisions
- Lead portfolio planning and prioritization with executive leadership, balancing near-term line extensions against longer-horizon platform bets
- Maintain a rigorous view of competitive pipelines, emerging technologies, and clinical trends in neuromodulation and adjacent therapy areas
New Product Pipeline & Development
- Identify and validate unmet needs through voice-of-customer research, KOL engagement, procedural observation, and market analysis
- Translate market insights into clear product requirements, target product profiles, and user needs documents for R&D
- Build and defend business cases for new product concepts, including market sizing, adoption modeling, pricing assumptions, and financial projections
- Serve as the marketing lead on core/phase-gate development teams, representing the customer and commercial perspective through design, verification, and validation
- Partner with Clinical and Regulatory on evidence strategy and claims development to ensure new products launch with a compelling, defensible value proposition
Launch Readiness & Commercial Handoff
- Define global launch strategy, positioning, and geographic sequencing for pipeline products well ahead of commercialization, spanning U.S. and OUS markets
- Lead the structured handoff to Downstream Marketing and Sales, ensuring launch plans, claims, and training foundations are in place
- Support limited market releases and early evaluator programs; capture feedback and drive iteration before full launch
Market Insight & Cross-Functional Leadership
- Serve as the company's authority on global market dynamics: market models, share tracking, customer segmentation, and procedural trends
- Build and manage KOL and physician advisory relationships to pressure-test concepts and shape the pipeline
- Mentor and develop upstream marketing talent as the function scales; manage direct reports as assigned
- Champion the voice of the customer in executive forums, portfolio reviews, and board-level discussions as required
What You’ll Bring:
Required
- Bachelor's degree in business, engineering, or life sciences; MBA or advanced degree preferred
- 10+ years of progressive medical device marketing experience with significant upstream/portfolio responsibility; neuromodulation, spine, or active implantable experience strongly preferred
- Demonstrated success taking multiple products from concept through development to launch as the upstream marketing lead
- Experience operating within a design control / phase-gate development process and partnering effectively with R&D
- Strong command of market modeling, business case development, and financial analysis
- Proven voice-of-customer and KOL engagement skills, including physician advisory boards and field-based research
- Experience assessing, prioritizing, and supporting launches in markets outside the U.S., including regulatory and reimbursement considerations by geography
- Executive presence and communication skills; comfortable presenting portfolio strategy to senior leadership
Preferred
- Experience with data-driven or closed-loop technologies, digital health, or products with a software/data component
- Prior work in a growth-stage company scaling from a single platform to a broader portfolio
Competencies for Success:
- Market-back thinker: starts with the customer and clinical problem, not the technology
- Strategic and rigorous: builds business cases that hold up under CFO scrutiny and board review
- Influencer without authority: aligns R&D, Clinical, and executive stakeholders around portfolio priorities
- Bias for action: thrives in a growth-stage company where the playbook is still being written
Our Core Values:
- People – Our first responsibility is to the patients we serve.
- Integrity – Do the right thing
- Pioneering – Lead Boldly, Change Lives, Disrupt the Status-Quo
- Performance – Win together – Deliver with Excellence.
Saluda Medical embraces diversity and equal opportunity. We are committed to building a team representative of a variety of backgrounds, perspectives and skills. We believe people are the source of our inspiration and innovation.
Saluda Medical does not accept non-solicited resumes or candidate submittals from search/recruiting agencies not already on Saluda Medical’s approved agency list. Unsolicited resumes or candidate information submitted to Saluda Medical by search/recruiting agencies not already on Saluda Medical’s approved agency list shall become the property of Saluda Medical.
Skills Required
- Bachelor's degree in business, engineering, or life sciences
- MBA or advanced degree
- 10+ years of progressive medical device marketing experience
- Significant upstream or portfolio marketing responsibility
- Experience in neuromodulation, spine, or active implantable medical devices
- Success taking multiple products from concept through development to launch as the upstream marketing lead
- Experience with design control or phase-gate development processes
- Ability to partner effectively with R&D
- Strong market modeling, business case development, and financial analysis skills
- Voice-of-customer and KOL engagement experience
- Experience with physician advisory boards and field-based research
- Experience supporting launches outside the United States
- Understanding of international regulatory and reimbursement considerations
- Executive presence and senior leadership presentation skills
- Experience with data-driven or closed-loop technologies, digital health, or software and data products
- Experience scaling a growth-stage company from a single platform to a broader portfolio
What We Do
Saluda Medical is a global company revolutionizing the field of neuromodulation with an emerging portfolio of therapies driven by advanced closed-loop technologies designed to treat debilitating neurological disorders. The company’s first product, the Evoke® System, is the only ECAP-controlled closed-loop spinal cord stimulation (SCS) system and is indicated as an aid in the management of chronic intractable pain of the trunk and/or limbs, including unilateral or bilateral pain associated with failed back surgery syndrome, intractable low back pain, and leg pain. The Evoke System instantaneously reads, records, and responds to the nerves’ response to stimulation to provide continually optimized therapy and is proven to be superior to open-loop SCS for the treatment of overall trunk and/or limb pain. 12-month results from the EVOKE Study, the first double-blind randomized controlled trial (RCT) used in support of Premarket Approval (PMA) in spinal cord stimulation history, were published in The Lancet Neurology and 24-month results have since been published JAMA Neurology. Both studies are poised to set new clinical standards for long-term pain relief and improvements in physical and emotional functioning, sleep quality and health-related quality of life. In the EU, Evoke is CE Marked and commercially available. In the U.S., Evoke is FDA-approved and will be available when the Company implements its full commercial release in 2023. Saluda Medical is a privately held company with headquarters in Bloomington, MN, USA. To learn more about Saluda Medical, including the risks & important safety information, visit www.saludamedical.com
.png)






